MicroRNA‑452 suppresses pancreatic cancer migration and invasion by directly targeting B‑cell‑specific Moloney murine leukemia virus insertion site 1

  • Authors:
    • Hongyan Li
    • Yan Wu
    • Peixiu Li
  • View Affiliations

  • Published online on: July 10, 2017     https://doi.org/10.3892/ol.2017.6566
  • Pages: 3235-3242
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pancreatic cancer, one of the most common cancers globally, is the fourth most common cause of cancer‑associated mortality in the USA. The 5‑year relative survival rate for patients with pancreatic cancer is ~5% and the median survival time is only 6 months. The poor prognosis is mainly due to early and aggressive local invasion and metastasis, as well as dissemination of the pancreatic cancer cells. The present study demonstrated that microRNA‑452 (miR‑452) was markedly downregulated in pancreatic cancer tissues, particularly in metastatic tumors and pancreatic cancer cell lines. Overexpression of miR‑452 significantly inhibited migration and invasion in pancreatic cancer cells. In addition, the molecular mechanism underlying the inhibitory functions of miR‑452 in pancreatic cancer was also investigated. The results indicated that B‑cell‑specific Moloney murine leukemia virus insertion site 1 (BMI1) was a direct target gene of miR‑452 in pancreatic cancer. Overexpression of miR‑452 inhibited the migration and invasion of pancreatic cancer, at least partially by knockdown of BMI1 expression. The results provided novel insight with potential therapeutic applications for the treatment of metastatic pancreatic cancer.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 14 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li H, Wu Y and Li P: MicroRNA‑452 suppresses pancreatic cancer migration and invasion by directly targeting B‑cell‑specific Moloney murine leukemia virus insertion site 1. Oncol Lett 14: 3235-3242, 2017
APA
Li, H., Wu, Y., & Li, P. (2017). MicroRNA‑452 suppresses pancreatic cancer migration and invasion by directly targeting B‑cell‑specific Moloney murine leukemia virus insertion site 1. Oncology Letters, 14, 3235-3242. https://doi.org/10.3892/ol.2017.6566
MLA
Li, H., Wu, Y., Li, P."MicroRNA‑452 suppresses pancreatic cancer migration and invasion by directly targeting B‑cell‑specific Moloney murine leukemia virus insertion site 1". Oncology Letters 14.3 (2017): 3235-3242.
Chicago
Li, H., Wu, Y., Li, P."MicroRNA‑452 suppresses pancreatic cancer migration and invasion by directly targeting B‑cell‑specific Moloney murine leukemia virus insertion site 1". Oncology Letters 14, no. 3 (2017): 3235-3242. https://doi.org/10.3892/ol.2017.6566